A National Survey of Oxytocin Use during Caesarean Section in Zimbabwe
East Afr. Med. J
; 93(1): 15-22, 2016.
Article
in English
| AIM
| ID: biblio-1261398
Responsible library:
CG1.1
ABSTRACT
Background:
Post-partum haemorrhage is the leading cause of mortality for labouring women in Zimbabwe. Current literature supports the use of low dose oxytocin to prevent bleeding during Caesarean section. Internationally; clinical practice has been slow to change and the use of potentially harmful; higher than recommended dose is common.Objective:
To describe the current clinical practice in Zimbabwe.Design:
A self-administered questionnaire survey. Descriptive statistics were used to report the study results.Setting:
In 2013 a national survey was conducted on the use of oxytocin by different types of clinicians; who provide either anaesthesia or surgery for Caesarean section.Results:
Of a total of 221 (61%) questionnaires returned; 170 (80%) were completed fully. Only 23% of respondents would give an intravenous dose of 5.0 IU or less of oxytocin for elective Caesarean section. The majority of clinicians (77%) would administer more than 5.0 IU of oxytocin at elective. A significant number of nurse anaesthetists 16/59 (27%); and a non-negligible number of specialist anaesthetists 3/48 (6%) would even give 20 IU of oxytocin in elective cases rising to 30% and 13% respectively for emergency cases. In case of persistent bleeding due to uterine atony; oxytocin was more likely to be repeated (45%); rather than using misoprostol (25%) or ergometrine (19%).Conclusion:
Most clinicians in Zimbabwe use oxytocin doses well above current internationally recommended. This illustrates the urgent need for updated national guidelines for the prevention of post-partum haemorrhage during Caesarean section
Search on Google
Index:
AIM (Africa)
Main subject:
Oxytocin
/
Cesarean Section
/
Surveys and Questionnaires
/
Hemorrhage
Type of study:
Practice guideline
/
Qualitative research
Language:
English
Journal:
East Afr. Med. J
Year:
2016
Type:
Article
Similar
MEDLINE
...
LILACS
LIS